UAE at a glance
- Population
- 11.5 million 2025
- Life expectancy at birth
- 83.1 years, 2024
- People aged 65 and over
- 1.8 % of people, 2025
- Health spending per person
- 2,402 US$ per person, 2023
- Doctors
- 2.99 per 1,000 people, 2023
Updated
Reviewed by Vidhi Upadhyay
UAE Benign Prostatic Hyperplasia Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$54.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $61.6 Mn | — | — |
| 2025 (base) | $65.8 Mn | +$4.2 Mn | — |
| 2026 (forecast) | $70.4 Mn | +$4.5 Mn | +6.9% |
| 2027 (forecast) | $75.2 Mn | +$4.9 Mn | +14.3% |
| 2028 (forecast) | $80.4 Mn | +$5.2 Mn | +22.2% |
| 2029 (forecast) | $86.0 Mn | +$5.5 Mn | +30.6% |
| 2030 (forecast) | $91.9 Mn | +$5.9 Mn | +39.6% |
| 2031 (forecast) | $98.2 Mn | +$6.3 Mn | +49.2% |
| 2032 (forecast) | $105.0 Mn | +$6.8 Mn | +59.5% |
| 2033 (forecast) | $112.3 Mn | +$7.2 Mn | +70.5% |
| 2034 (forecast) | $120.0 Mn | +$7.7 Mn | +82.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $65.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $120.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Treatment, setting and end user (see all) |
| Key players | Boston Scientific Corporation, Teleflex Inc, Olympus Corporation, Procept BioRobotics, Astellas Pharma Inc. (see all) |
| Regulator in the UAE | EDESource: Emirates Drug Establishment. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Benign prostatic hyperplasia treatments ease urinary problems from an enlarged prostate with medicines and minimally invasive procedures.
Key segments of the benign Prostatic Hyperplasia Treatment market include treatment (Alpha Blockers, 5-Alpha Reductase Inhibitors and Prostatic Urethral Lift) and setting (Hospitals, Urology Clinics and Ambulatory Surgery Centers).
An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the benign Prostatic Hyperplasia Treatment market.
Office-based procedures, direct-to-consumer telehealth and wider insurance coverage give the benign Prostatic Hyperplasia Treatment market room to grow.
Stigma, out-of-pocket costs and limited reimbursement for some procedures hold back the benign Prostatic Hyperplasia Treatment market.
The benign Prostatic Hyperplasia Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention.[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.[2]
[1] Emirates Drug Establishment. Checked 14 Nov 2026.
[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how benign Prostatic Hyperplasia Treatment products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UAE.
What doctors and scientists are doing in Benign Prostatic Hyperplasia Treatment right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
UAE · 2 shared keywords
UAE · 2 shared keywords
UAE · 2 shared keywords
UAE · 1 shared keyword
UAE · 1 shared keyword
UAE · 1 shared keyword
Pharmaceuticals · UAE
Healthcare Services · UAE
Pharmaceuticals · UAE
Healthcare Services · UAE
Healthcare Services · UAE
Pharmaceuticals · UAE